FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...